Beta-adrenergic blockade in thyrotoxic myopathy.
D000255:Adenosine Triphosphate / Q000378:metabolism; D000328:Adult; D000368:Aged; D001692:Biological Transport; D002395:Catecholamines / Q000378:metabolism / Q000502:physiology; D004576:Electromyography; D005260:Female; D006801:Humans; D006980:Hyperthyroidism / Q000150:complications*; D008875:Middle Aged; D009132:Muscles / Q000378:metabolism; D009135:Muscular Diseases / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D010085:Oxidative Phosphorylation; D010710:Phosphates / Q000378:metabolism; D011188:Potassium / Q000378:metabolism; D011433:Propranolol / Q000008:administration & dosage / Q000627:therapeutic use*; D012964:Sodium / Q000378:metabolism
D002395:Catecholamines; D010710:Phosphates; D000255:Adenosine Triphosphate; D012964:Sodium; D011433:Propranolol; D011188:Potassium